<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=384506&amp;fmt=gif">
Skip to content
    January 4, 2012

    Collaboration as the key to turning around the drug discovery business (Part 6) - Technology can make things easier

    Making Hard Things Easier

    scienceishard

    Science is hard.  Drug Discovery is hard.  Chemistry is hard.  Biology is hard.  Business is hard.  Innovation is hard.  Management is hard.

    Technology can make things easier.  Some technologies make a little impact.  Other technologies, such as the printing press in years past and the linking of computers via the Internet more recently, have a non-linear impact and touch upon nearly all elements of our life. Nearly every experimental result can be improved by an additional insight, perspective, or experiment.  This is the basis of scientific progress.  What if we could tap into the aggregated, collective, immediate results of all drug discovery scientists worldwide? Can we more optimally balance intellectual property control with the benefit of collective learning?  Imagine drug discovery progressing at the speed of the Internet.  Imagine the tremendous global human health benefit of easy, simultaneous competition and collaboration. Imagine if we could meaningfully aggregate our collective drug discovery knowledge, efforts, and experiments.


    For full context, find the link to each entry of our 12-part series, "Collaboration is the Key to Turning Around the Drug Discovery Business" using the links below:

    Read Part 1: Collaboration as the key for turning around the drug discovery business – The Problem

    Read Part 2: Collaboration as the key for turning around the drug discovery business – The Hypothesis

    Read Part 3: Collaboration as the key for turning around the drug discovery business – A Solution

    Read Part 4: Collaboration as the key to turning around the drug discovery business – Collaboration and Innovation

    Read Part 5: Collaboration as the key to turning around the drug discovery business - A Monte Carlo Simulation

    Read Part 6: Collaboration as the key to turning around the drug discovery business - Technology can Make Things Easier

    Read Part 7: Collaboration as the key to turning around the drug discovery business: Collaboration = Leverage

    Read Part 8: Collaboration as the key to turning around the drug discovery business – Standards

    Especially read Part 9:  Collaboration as the key to turning around the drug discovery business - Collaborate Better

    Part 10:  Collaboration as the key to turning around the drug discovery business - Learning from eBay, NASDAQ, Airlines, & Hollywood

    Part 11: Collaborative as the key to turning around the drug discovery business - The Future

    Part 12: Collaboration as the key to turning around the drug discovery business

    P.S. Beyond collaboration as a more enlightened approach to science, here are the top 5 practical reasons collaborative scientists rock with CDD: 5 Reasons Why Collaborative Scientists Use CDD

    You can also download the full series “Collaboration as the key to turning around the drug discovery business” by Barry Bunin as a pdf document:

    full-series


    This blog is authored by members of the CDD Vault community. CDD Vault is a hosted drug discovery informatics platform that securely manages both private and external biological and chemical data. It provides core functionality including chemical registrationstructure activity relationshipchemical inventory, and electronic lab notebook capabilities!

    CDD Vault: Drug Discovery Informatics your whole project team will embrace!

    Other posts you might be interested in

    View All Posts
    CDD Blog
    2 min   April 22, 2024
    Recorded Presentations: CDD 20th Anniversary User Group Meeting
    Read More
    CDD Blog
    9 min   April 19, 2024
    Drug Discovery Industry Roundup with Barry Bunin — April 19, 2024
    Read More
    CDD Blog
    2 min   April 19, 2024
    CDD Appoints Yasushi Hamagashira as Head of Sales and Marketing for Japan
    Read More